Listeria monocytogenes mediated CFTR transgene transfer to mammalian cells

Journal of Gene Medicine

Volumn 4, Issue 6, 2002, Pages 655-667

  Krusch, Stefan ^a   Domann, Eugen ^b   Frings, Monika ^b   Zelmer, Andrea ^a   Diener, Martin ^b   Chakraborty, Trinad ^b   Weiss, Siegfried ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Attenuation; Bacterial vectors; CFTR; Gene transfer

Indexed keywords

ANTIBIOTIC AGENT; COMPLEMENTARY DNA; HEMOLYSIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA TRANSFER; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC ENGINEERING; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MAMMAL CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; ANIMAL; CHO CELL; CONFOCAL MICROSCOPY; FLUORESCENCE MICROSCOPY; GENETICS; HAMSTER; PLASMID; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); EUKARYOTA; LISTERIA MONOCYTOGENES; MAMMALIA;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LISTERIA MONOCYTOGENES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PATCH-CLAMP TECHNIQUES; PLASMIDS;

EID: 0042573181     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.313     Document Type: Article

References (62)

1. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245 1073-1080.
2. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
3. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
4. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999; 79: S23-S45.
5. Schwiebert EM, Benos DJ, Egan ME, et al. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 1999; 79: S145-S166.
6. Bradbury NA. Intracellular CFTR: localization and function. Physiol Rev 1999; 79: S175-S191.
7. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993; 341: 1065-1069.
8. Drumm ML, Pope HA, Cliff WH, et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990; 62: 1227-1233.
9. Rich DP, Anderson MP, Gregory RJ, et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990; 347: 358-363.
10. Johnson LG, Olsen JC, Sarkadi B, et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992; 2: 21-25.
11. Rosenfeld MA, Yoshimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
12. Alton EW, Middleton PG, Caplen NJ, et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135-142.
13. Hyde SC, Gill DR, Higgins CF, et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250-255.
14. Davies JC, Geddes DM, Alton EW. Gene therapy for cystic fibrosis. J Gene Med 2001; 3: 409-417.
15. Weiss S, Krusch S. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol Chem 2001; 382: 533-541.
16. Darji A, Guzman CA, Gerstel B, et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997; 91: 765-775.
17. Fennelly GJ, Khan SA, Abadi MA, et al. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J Immunol 1999; 162: 1603-1610.
18. Shiau AL, Chen YL, Liao CY, et al. Prothymosin-α enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis. Vaccine 2001; 19: 3947-3956.
19. Courvalin P, Goussard S, Grillot-Courvalin C. Gene transfer from bacteria to mammalian cells. C R Acad Sci III 1995; 318: 1207-1212.
20. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995; 270: 299-302.
21. Dietrich G, Kolb-Mäurer A, Spreng S, et al. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Vaccine 2001; 19: 2506-2512.
22. Dietrich G, Bubert A, Gentschev I, et al. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol 1998; 16: 181-185.
23. Grillot-Courvalin C, Goussard S, Huetz F, et al. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotechnol 1998; 16: 862-866.
24. Kunik T, Tzfira T, Kapulnik Y, et al. Genetic transformation of HeLa cells by Agrobacterium. Proc Natl Acad Sci U S A 2001; 98: 1871-1876.
25. Paglia P, Terrazzini N, Schulze K, et al. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery. Gene Ther 2000; 7: 1725-1730.
26. Montosi G, Paglia P, Garuti C, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000; 96: 1125-1129.
27. Xiang R, Lode HN, Chao TH, et al. An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci U S A 2000; 97: 5492-5497.
28. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 1997; 15: 804-807.
29. Paglia P, Medina E, Arioli I, et al. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 1998; 92: 3172-3176.
30. Brunham RC, Zhang D. Transgene as vaccine for chlamydia. Am Heart J 1999; 138: S519-S522.
31. Pasetti MF, Anderson RJ, Noriega FR, et al. Attenuated ΔguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin Immunol 1999; 92: 76-89.
32. Anderson RJ, Pasetti MF, Sztein MB, et al. ΔguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin. Vaccine 2000; 18: 2193-2202.
33. Darji A, zur Lage S, Garbe AI, et al. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 2000; 27: 341-349.
34. Spreng S, Dietrich G, Niewiesk S, et al. Novel bacterial systems for the delivery of recombinant protein or DNA. FEMS Immunol Med Microbiol 2000; 27: 299-304.
35. Urashima M, Suzuki H, Yuza Y, et al. An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium. Blood 2000; 95: 1258-1263 [published erratum appears in Blood 2000 15: 3652].
36. Yuhua L, Kunyuan G, Hui C, et al. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium. Int J Cancer 2001; 94: 438-443.
37. Hense M, Domann E, Krusch S, et al. Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells. Cell Microbiol 2001; 3: 599-609.
38. Chakraborty T, Wehland J. The host cell infected with L. monocytogenes. In Host Response to Intracellular Pathogens, Kaufmann SHE (ed). Landee Company: Austin, 1997; 271-290.
39. O'Riordan CR, Erickson A, Bear C, et al. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. J Biol Chem 1995; 270: 17 033-17 043.
40. Chang XB, Kartner N, Seibert FS, et al. Heterologous expression systems for study of cystic fibrosis transmembrane conductance regulator. Methods Enzymol 1998; 292: 616-629.
41. - channels expressed in mammalian cells. J Physiol 1998; 508: 379-392.
42. Jacobs T, Darji A, Weiss S, et al. Listeriolysin, the thiol-activated hemolysin of Listeria monocytogenes. In The Comprehensive Sourcebook of Bacterial Protein Toxins, Alouf P (ed). Academic Press: New York, 1999; 511-521.
43. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual, Nolan C (ed). Cold Spring Harbor Laboratory Press: New York, 1989.
44. Park SF, Stewart GS. High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells. Gene 1990; 94: 129-132.
45. Guzman CA, Domann E, Rohde M, et al. Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol Microbiol 1996; 20 119-126.
46. Chakraborty T, Leimeister-Wächter M, Domann E, et al. Coordinate regulation of virulence genes in Listeria monocytogenes requires the product of the prfA gene. J Bacteriol 1992; 174: 568-574.
47. Guzman CA, Rohde M, Chakraborty T, et al. Interaction of Listeria monocytogenes with mouse dendritic cells. Infect Immunol 1995; 63: 3665-3673.
48. Leimeister-Wächter M, Haffner C, Domann E, et al. Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of Listeria monocytogenes. Proc Natl Acad Sci U S A 1990; 87: 8336-8340.
49. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
50. Darji A, Niebuhr K, Hense M, et al. Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation. Infect Immunol 1996; 64: 2356-2358.
51. Kälin N, Claass A, Sommer M, et al. ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest 1999; 103: 1379-1389.
52. Drevets DA, Canono BP, Leenen PJ, et al. Gentamicin kills intracellular Listeria monocytogenes. Infect Immunol 1994; 62: 2222-2228.
53. Jain V, Mekalanos JJ. Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar Typhimurium-based DNA vaccine delivery systems. Infect Immunol 2000; 68: 986-989.
54. Germanier R, Fürer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975; 131: 553-558.
55. Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-239.
56. Noriega FR, Wang JY, Losonsky G, et al. Construction and characterization of attenuated ΔaroA ΔvirG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immunol 1994; 62: 5168-5172.
57. Noriega FR, Losonsky G, Lauderbaugh C, et al. Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine. Infect Immunol 1996; 64: 3055-3061.
58. Wang JY, Pasetti MF, Noriega FR, et al. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated ΔguaBA Salmonella enterica serovar Typhi strain CVD915. Infect Immunol 2001; 69: 4734-4741.
59. Leung KY, Finlay BB. Intracellular replication is essential for the virulence of Salmonella typhimurium. Proc Natl Acad Sci U S A 1991; 88: 11 470-11 474.
60. North RJ, Berche PA, Newborg MF. Immunologic consequences of antibiotic-induced abridgement of bacterial infection: effect on generation and loss of protective T cells and level of immunologic memory. J Immunol 1981; 127: 342-346.
61. Mielke ME, Ehlers S, Hahn H. The role of cytokines in experimental listeriosis. Immunobiology 1993; 189: 285-315.
62. Leimeister-Wächter M, Chakraborty T. Detection of listeriolysin, the thiol-dependent hemolysin in Listeria monocytogenes, Listeria ivanovii, and Listeria seeligeri. Infect Immunol 1989; 57: 2350-2357.